Stocks with high levels of insider buying the past 3 months and good analyst coverage.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
388	HK$385.00	2.7%	-9.5%	HK$486.7b	HK$515.76	25.8	4.9%	3.4%	Diversified Financials
9633 New	HK$39.74	-4.6%	1.6%	HK$446.9b	HK$55.25	24.4	10.9%	2.9%	Food, Beverage & Tobacco
175	HK$18.64	1.9%	6.0%	HK$201.0b	HK$28.96	11.3	16.8%	2.7%	Automobiles
6 New	HK$58.45	1.2%	17.1%	HK$124.6b	HK$66.20	20.0	0.4%	4.8%	Utilities
823	HK$37.44	-1.3%	-11.2%	HK$97.3b	HK$45.23	0.6	51.3%	6.8%	Real Estate
1093	HK$8.11	1.4%	2.1%	HK$92.7b	HK$11.48	24.6	14.6%	3.6%	Pharmaceuticals & Biotech
1177	HK$5.19	9.5%	-12.5%	HK$92.5b	HK$8.59	34.1	16.9%	1.9%	Pharmaceuticals & Biotech
9926	HK$97.25	-5.0%	-14.1%	HK$89.6b	HK$171.75	25.3	46.8%	n/a	Pharmaceuticals & Biotech
6181	HK$391.20	2.4%	-56.5%	HK$69.1b	HK$842.24	12.3	18.3%	7.1%	Consumer Durables
6862	HK$10.95	-2.1%	-25.3%	HK$61.0b	HK$17.64	13.0	9.5%	6.6%	Consumer Services
9863	HK$37.74	2.7%	-34.6%	HK$53.7b	HK$66.61	86.1	38.7%	n/a	Automobiles
1364	HK$20.06	-7.6%	-29.2%	HK$47.7b	HK$32.46	13.3	14.1%	2.5%	Consumer Services
1530	HK$18.07	-7.6%	-28.2%	HK$45.2b	HK$34.77	4.6	-38.2%	1.4%	Pharmaceuticals & Biotech
960	HK$6.10	-1.8%	-41.5%	HK$43.3b	HK$10.24	36.6	33.6%	0%	Real Estate Management and Development
3939	HK$9.40	-1.9%	30.1%	HK$41.4b	HK$15.74	26.4	46.6%	1.8%	Materials
1828	HK$29.00	3.3%	-24.8%	HK$37.1b	HK$44.75	28.5	28.4%	n/a	Insurance
101	HK$7.10	-1.3%	-4.4%	HK$36.9b	HK$10.44	20.5	17.2%	7.3%	Real Estate Management and Development
23	HK$13.06	2.4%	6.2%	HK$34.5b	HK$14.26	0.3	25.9%	4.7%	Banks
2096	HK$12.09	5.4%	15.8%	HK$31.0b	HK$17.79	20.0	18.0%	1.7%	Pharmaceuticals & Biotech
1044	HK$23.16	2.0%	-0.4%	HK$26.8b	HK$28.49	9.1	3.3%	7.0%	Household
1318	HK$50.65	-10.0%	-48.5%	HK$24.8b	HK$100.74	17.8	16.9%	2.3%	Household
290 New	HK$2.37	13.9%	34.7%	HK$24.4b	n/a	14.1	n/a	n/a	Diversified Financials
3800	HK$0.64	-5.9%	-48.0%	HK$21.3b	HK$1.49	1.3	89.6%	0%	Semiconductors
9606	HK$223.40	3.8%	-22.4%	HK$20.2b	HK$433.98	9.4	98.3%	n/a	Pharmaceuticals & Biotech

High Insider Buying